You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • SAT0180 Efficacy and safety of sarilumab 200 MG Q2W administered as combination therapy or monotherapy in different patient populations with active RA

Alerts

Article menu

Download PDFPDF

Poster Presentations
Rheumatoid arthritis - other biologic treatment
SAT0180 Efficacy and safety of sarilumab 200 MG Q2W administered as combination therapy or monotherapy in different patient populations with active RA
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address